Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone-based mouthwash for prevention of chemotherapy-induced stomatitis in breast cancer
jRCTs071240036Phase 3Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in breast cancer and stomatitis (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Incidence of all-grade stomatitis by ePRO. Started Jul 2024; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
breast cancerstomatitis
Beyond the preview
Go deeper on jRCTs071240036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071240036.